Home » Newsletters » BioWorld Science

BioWorld Science

March 15, 2017

View Archived Issues

AMO Pharma and Ranedis collaborate on development of RND-001 for rare genetic diseases

Biocept and Catalyst agree to use liquid biopsy testing to screen for SCLC in Firdapse trial

Vedantra and Neon Therapeutuics collaborate on cancer vaccine research

MRC Technology licenses antibody to Newsummit for development in HCV

GABA(A) receptor inhibition stimulates retinal regeneration in novel zebrafish model

Mayo Clinic secures grant to study TapImmune's HER2-targeted vaccine for ductal carcinoma in situ

Allergan and Editas Medicine establish ocular research and development alliance

REGiMMUNE presents phase IIa data for RGI-2001

Lung Therapeutics initiates phase Ia/Ib study of LTI-01 to treat loculated pleural effusions

Targeting tumor-associated macrophage progenitors as a new strategy to impair tumor growth

FDA approves Keytruda for classical Hodgkin's lymphoma

Replicel completes phase I study of autologous cell therapy RCH-01 for androgenetic alopecia

Galectin Therapeutics reports promising results for GR-MD-02 in severe refractory atopic dermatitis

Pulmonary surfactant-associated protein D, a potential target for seasonal allergic rhinitis

Metriopharm reports topline results from phase IIa study of MP-1032 in plaque psoriasis

EnzymeBioSystems offers update on methyl amooranin

University of California, Oakland presents nitroxide spin-labeled compounds targeting beta-amyloid

New trial explores intracerebroventricular delivery of valproate for refractory epilepsy

Takeda Pharmaceutical patents histone deacetylase inhibitors

High PMS2 expression linked to reduced urothelial bladder cancer survival

Oncoceutics announces new DRD2 research collaborations with NIH

GeoVax Labs collaborates with American Gene Technologies on functional cure for HIV

CD300a found to play a role in atopic dermatitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...